Anzeige
Mehr »
Dienstag, 24.02.2026 - Börsentäglich über 12.000 News
Von Polen bis Virginia Beach- zündet hier der nächste Smallcap-Turbo?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40M9J | ISIN: US83558L3033 | Ticker-Symbol: O8Z
Lang & Schwarz
24.02.26 | 07:00
2,480 Euro
-100,00 % -2,480
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SONOMA PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
SONOMA PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
2,4402,52007:00

Aktuelle News zur SONOMA PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
10.02. Sonoma Pharmaceuticals GAAP EPS of -$0.48, revenue of $4.3M1
10.02.Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results352Revenue increased 22% for the quarter ended December 31, 2025 and 33% for the nine months ended December 31, 2025 compared to prior yearNet loss and net loss per share decreased from prior year for...
► Artikel lesen
10.02.Sonoma Pharmaceuticals, Inc. - 10-Q, Quarterly Report2
28.01.Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President of Regulatory, Quality and Product Development476BOULDER, CO / ACCESS Newswire / January 28, 2026 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn technology based stabilized hypochlorous...
► Artikel lesen
28.01.Sonoma Pharmaceuticals, Inc. - 8-K, Current Report2
12.01.Sonoma Pharmaceuticals, Inc. - 8-K, Current Report2
02.01.Sonoma Pharmaceuticals, Inc. - 8-K, Current Report2
SONOMA PHARMACEUTICALS Aktie jetzt für 0€ handeln
13.11.25Sonoma Pharmaceuticals, Inc.: National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced394BOULDER, CO / ACCESS Newswire / November 13, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous...
► Artikel lesen
06.11.25Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf329BOULDER, CO / ACCESS Newswire / November 6, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous...
► Artikel lesen
04.11.25Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results225Revenues increased 57% for the quarter and 38% for the six months ended September 30, 2025 compared to same periods last yearU.S. revenue increased 115% for the quarter and 86% for the six months ended...
► Artikel lesen
04.11.25Sonoma Pharmaceuticals, Inc. - 10-Q, Quarterly Report2
23.10.25Sonoma Pharmaceuticals, Inc. - 8-K, Current Report1
14.10.25Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals345BOULDER, CO / ACCESS Newswire / October 14, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader in developing and producing stabilized hypochlorous acid (HOCl) products based...
► Artikel lesen
09.10.25Sonoma Pharmaceuticals, Inc. - 8-K, Current Report3
07.10.25Sonoma Pharmaceuticals registers under FDA's cosmetics act3
07.10.25Sonoma Pharmaceuticals registers HOCl facial spray under U.S. cosmetics law6
07.10.25Sonoma Pharmaceuticals: FDA-Registrierung ebnet Weg in US-Kosmetikmarkt4
07.10.25Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA343BOULDER, COLORADO / ACCESS Newswire / October 7, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized...
► Artikel lesen
26.09.25Sonoma Pharma schließt 'At-the-Market'-Verkaufsvereinbarung über bis zu 2,07 Mio. US-Dollar ab3
26.09.25Sonoma Pharmaceuticals, Inc. - 8-K, Current Report1
Weiter >>
32 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1